235 related articles for article (PubMed ID: 32479428)
1. A Novel Nomogram Based on Immune Scores for Predicting Survival in Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC).
Wu Z; Ouyang C; Peng L
Med Sci Monit; 2020 Jun; 26():e923231. PubMed ID: 32479428
[TBL] [Abstract][Full Text] [Related]
2. An immune scores-based nomogram for predicting overall survival in patients with clear cell renal cell carcinoma.
Wu Z; Ouyang C; Peng L
Medicine (Baltimore); 2020 Aug; 99(34):e21693. PubMed ID: 32846785
[TBL] [Abstract][Full Text] [Related]
3. An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy.
Wang Y; Qu X; Kam NW; Wang K; Shen H; Liu Q; Du J
BMC Cancer; 2018 Jun; 18(1):692. PubMed ID: 29940884
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
5. The advanced lung cancer inflammation index (ALI) predicted the postoperative survival rate of patients with non-small cell lung cancer and the construction of a nomogram model.
Ma S; Li Z; Wang L
World J Surg Oncol; 2024 Jun; 22(1):158. PubMed ID: 38877553
[TBL] [Abstract][Full Text] [Related]
6. Prognostic nomogram based on pre-treatment HALP score for patients with advanced non-small cell lung cancer.
Gao S; Huang Q; Wei S; Lv Y; Xie Y; Hao Y
Clinics (Sao Paulo); 2024; 79():100371. PubMed ID: 38735175
[TBL] [Abstract][Full Text] [Related]
7. [A Prognostic Model of Elderly Patients with Non-small Cell Lung Cancer
Based on Geriatric Nutritional Risk Index].
Zhang X; Xiong Y; Xu A
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):497-506. PubMed ID: 37653013
[TBL] [Abstract][Full Text] [Related]
8. Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers.
Xie D; Allen MS; Marks R; Jiang G; Sun Z; Nichols F; Zhang M; Chen C; Aubry MC; Jatoi A; Garces YI; Mansfield A; Wigle D; Molina J; Deschamps C; Yang P
Eur J Cardiothorac Surg; 2018 Jun; 53(6):1214-1222. PubMed ID: 29293957
[TBL] [Abstract][Full Text] [Related]
9. Two nomograms constructed for predicting the efficacy and prognosis of advanced non‑small cell lung cancer patients treated with anti‑PD‑1 inhibitors based on the absolute counts of lymphocyte subsets.
Liu A; Zhang G; Yang Y; Xia Y; Li W; Liu Y; Cui Q; Wang D; Yu J
Cancer Immunol Immunother; 2024 Jun; 73(8):152. PubMed ID: 38833153
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
[TBL] [Abstract][Full Text] [Related]
11. Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.
Kang J; Ning MS; Feng H; Li H; Bahig H; Brooks ED; Welsh JW; Ye R; Miao H; Chang JY
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):90-99. PubMed ID: 31586665
[TBL] [Abstract][Full Text] [Related]
12. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
Chai Y; Ma Y; Feng W; Lu H; Jin L
World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
[TBL] [Abstract][Full Text] [Related]
13. Establishment and validation of a predictive nomogram model for non-small cell lung cancer patients with chronic hepatitis B viral infection.
Chen S; Lai Y; He Z; Li J; He X; Shen R; Ding Q; Chen H; Peng S; Liu W
J Transl Med; 2018 May; 16(1):116. PubMed ID: 29728103
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer.
Liang W; Zhang L; Jiang G; Wang Q; Liu L; Liu D; Wang Z; Zhu Z; Deng Q; Xiong X; Shao W; Shi X; He J
J Clin Oncol; 2015 Mar; 33(8):861-9. PubMed ID: 25624438
[TBL] [Abstract][Full Text] [Related]
15. A nomogram from the SEER database for predicting the prognosis of patients with non-small cell lung cancer.
Zeng B; Ji P; Chen C; Sun J; Gu C; Shang A; Wu J; Sun Z; Li D
Int J Biochem Cell Biol; 2020 Oct; 127():105825. PubMed ID: 32898690
[TBL] [Abstract][Full Text] [Related]
16. Prediction and verification of survival in patients with non-small-cell lung cancer based on an integrated radiomics nomogram.
Li R; Peng H; Xue T; Li J; Ge Y; Wang G; Feng F
Clin Radiol; 2022 Mar; 77(3):e222-e230. PubMed ID: 34974912
[TBL] [Abstract][Full Text] [Related]
17. Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
Jacobs CD; Mehta K; Gao J; Wang X; Salama JK; Kelsey CR; Torok JA
Clin Lung Cancer; 2022 Mar; 23(2):177-184. PubMed ID: 34301453
[TBL] [Abstract][Full Text] [Related]
18. Construction of a nomogram to predict the prognosis of non-small-cell lung cancer with brain metastases.
Huang Z; Hu C; Tong Y; Fan Z; Zhao C
Medicine (Baltimore); 2020 Jul; 99(31):e21339. PubMed ID: 32756121
[TBL] [Abstract][Full Text] [Related]
19. Five long non-coding RNAs establish a prognostic nomogram and construct a competing endogenous RNA network in the progression of non-small cell lung cancer.
Yu Y; Ren K
BMC Cancer; 2021 Apr; 21(1):457. PubMed ID: 33892664
[TBL] [Abstract][Full Text] [Related]
20. Prognostic nomogram based on immune scores for breast cancer patients.
Wang J; Li Y; Fu W; Zhang Y; Jiang J; Zhang Y; Qi X
Cancer Med; 2019 Sep; 8(11):5214-5222. PubMed ID: 31342666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
